Clinical Trials Browser

Phase EARLY_PHASE1 × tremelimumab × Genitourinary × Clear all

NCT02626130 2022-07-07

Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney Cancer

Phase EARLY_PHASE1 Completed

Carcinoma, Renal Cell